Infantile hemangiomas with conjunctival involvement: An underreported occurrence

Pediatr Dermatol. 2017 Nov;34(6):681-685. doi: 10.1111/pde.13305.

Abstract

Background/objectives: Infantile hemangiomas (IHs) involving the conjunctiva are only anecdotally reported in the literature and little is known about their clinical course. In a retrospective case series we aimed to better delineate the clinical presentation, complications, and response to treatment of this uncommon subtype of IH. A classification of conjunctival IH is proposed.

Methods: Medical charts at three academic pediatric dermatology institutions were retrospectively analyzed. Data were collected on the clinical characteristics, ophthalmologic findings, treatments, and outcomes of 22 individuals with conjunctival IH.

Results: Growth characteristics of conjunctival IH closely mirrored those of their cutaneous counterparts. Ophthalmologic abnormalities were associated with the IH in six individuals (27%); in three, they were considered severe. Seventeen subjects (77%) required treatment, most commonly because of risk of ocular compromise. All treated individuals responded favorably to topical timolol or systemic propranolol.

Conclusion: Conjunctival IH have clinical characteristics similar to those of cutaneous IH and respond readily to beta-blocker treatment. Ocular complications may occur in a minority of individuals receiving treatment.

Keywords: conjunctiva; eye; infantile hemangioma.

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Conjunctiva / pathology*
  • Conjunctival Neoplasms / diagnosis*
  • Conjunctival Neoplasms / drug therapy
  • Conjunctival Neoplasms / pathology
  • Female
  • Follow-Up Studies
  • Hemangioma / complications
  • Hemangioma / diagnosis*
  • Hemangioma / drug therapy
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists